New specials products added to dm+d
New specials products added to dm+d
September 18, 2020
Following representations made by PSNC, a total of 24 new unlicensed products (see table below) have been added to NHS dictionary of medicines and devices (dm+d) as ‘(Special Order)’ or ‘(Imported (Country))’ listings.
Due to ongoing supply issues affecting the availability of certain licensed products and following recommendations for prescribers to consider the prescribing of unlicensed alternatives as indicated in recent Medicine Supply Notification updates published by the Department of Health and Social Care (DHSC), PSNC requested the addition of new ‘(Special Order)’ or ‘(Imported (Country))’ dm+d listings in order to enable more electronic prescribing of these unlicensed products. The addition of any recommended unlicensed alternatives to dm+d means prescribing system suppliers can opt to make these selectable for prescribers so they can prescribe such items for both paper and EPS prescriptions, where appropriate, so that pharmacists can dispense the required product and be reimbursed accordingly. It also avoids pharmacy teams from having to request handwritten paper FP10 prescriptions or refer patients back to their GP for an alternative.
Over the past 12 months, PSNC has monitored the supply updates communicated by DHSC and submitted applications for all recommended unlicensed alternatives to be added to dm+d as quickly as possible. Of the requests submitted by PSNC, to date a total of 24 products have recently been added to dm+d by NHS Business Services Authority (NHSBSA). Previously, there were no Actual Medicinal Product (AMP) dm+d entries for prescribing system suppliers to be able to map to so that prescribers could then prescribe them via EPS. PSNC will continue to work with DHSC to ensure that any new specials products recommended as suitable alternatives are added to dm+d in a timely manner.
Table: List of new special products recently added to dm+d
|Generic or Virtual Medicinal Product (VMP) name||Brand or Actual Medicinal Product (AMP) name|
|Bupropion 150mg modified release tablets||Bupropion 150mg modified-release tablets (Imported)|
|Cimetidine 200mg tablets||Cimetidine 200mg tablets (Imported)|
|Cimetidine 400mg tablets||Cimetidine 400mg tablets (Imported)|
|Cimetidine 800mg tablets||Cimetidine 800mg tablets (Imported)|
|Cycloserine 250mg capsules||Cycloserine 250mg capsules (Imported)|
|Desmopressin 150micrograms/dose nasal spray||Desmopressin 150micrograms/dose nasal spray (Imported)|
|Desmopressin 150micrograms/dose nasal spray (Special Order)|
|Enalapril 20mg tablets||Enalapril 20mg tablets (Imported)|
|Fluoxetine 10mg tablets||Fluoxetine 10mg tablets (Imported)|
|Fluoxetine 30mg capsules||Fluoxetine 30mg capsules (Imported)|
|Fluoxetine 40mg capsules||Fluoxetine 40mg capsules (Imported)|
|Fluoxetine 40mg capsules (Special Order)|
|Fluticasone 500micrograms/2ml nebuliser liquid unit dose vials||Fluticasone 500micrograms/2ml nebuliser liquid unit dose vials (Imported)|
|Fluticasone 2mg/2ml nebuliser liquid unit dose vials||Fluticasone 2mg/2ml nebuliser liquid unit dose vials (Imported)|
|Ketotifen 1mg/5ml oral solution sugar free||Ketotifen 1mg/5ml oral solution sugar free (Imported)|
|Ketotifen 1mg/5ml oral solution sugar free (Special Order)|
|Mianserin 10mg tablets||Mianserin 10mg tablets (Imported)|
|Mianserin 30mg tablets||Mianserin 30mg tablets (Imported)|
|Mirtazapine 15mg orodisperible tablets||Mirtazapine 15mg orodisperible tablets (Imported)|
|Mirtazapine 45mg orodispersible tablets||Mirtazapine 45mg orodisperible tablets (Imported)|
|Moclobemide 300mg tablets||Moclobemide 300mg tablets (Imported)|
|Nabumetone 500mg tablets||Nabumetone 500mg tablets (Imported)|
|Pethidine 50mg tablets||Pethidine 50mg tablets (Imported)|
|Phenelzine 15mg capsules||Phenelzine 15mg capsules (Imported)|
|Phenelzine 15mg capsules (Special Order)|
|Phenelzine 15mg tablets||Phenelzine 15mg tablets (Special Order)|
|Prednsiolone sodium phosphate 5mg suppositories||Prednsiolone sodium phosphate 5mg suppositories (Imported)|
|Zafirlukast 20mg tablets||Zafirlukast 20mg tablets (Special Order)|
Please note: The correct AMP product listing should be selected by prescribers when using their prescribing systems to ensure that the required product is supplied by the pharmacy so that contractors can be reimbursed accordingly. Click here for further information on dispensing incorrectly written prescriptions for specials.
Non-Part VIIIB specials should be endorsed with the following information:
- Amount dispensed over pack size used;
- Invoice price per pack size from which the order was supplied less any discount or rebate;
- Initials ‘SP’ (which attracts a fixed fee of £20)
- Manufacturers’/importers’ MHRA licence number;
- Batch number of the product supplied;
These unlicensed products automatically qualify for Group Item Discount Not Deducted (DND) status meaning that no discount deduction will be applied to their reimbursement prices.
Note: GP system suppliers currently undertake to map no less than 95% of the most frequently prescribed drugs in primary care. Prescribing system suppliers should continue to map to greater numbers of dm+d listings so that more prescriptions can be sent via EPS instead of only via paper prescriptions. More about dm+d mapping at our dm+d webpage.